-
and optimize specific functions. The ICMCB carries out fundamental research on model materials and/or materials with potential applications. The ICMCB is a UMR with an average of 280 agents (permanent
-
for the development of innovative therapies. Radiotheranostic, a rising field in nuclear oncology, enables the visualization of tumor biomarkers and the application of a complementary personalized therapeutic agent. It
Searches related to agent gis
Enter an email to receive alerts for agent-gis positions